//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
In a landmark decision for people with early #type1diabetes (T1D) in the #UK, #Sanofi's first-of-its-kind therapy #Tzield, which can delay progression of the disease, has been given a green light for use by the #NHS. buff.ly/jPGDv2U
3h
pharmaphorum